Form 8-K - Current report:
SEC Accession No. 0000950123-03-007589
Filing Date
2003-06-27
Accepted
2003-06-27 14:05:19
Documents
5
Period of Report
2003-06-12
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y87978e8vk.txt 8-K 7678
3 CONSENT OF KPMG LLP y87978exv23w1.txt EX-23.1 2361
4 PRESS RELEASE y87978exv99w1.txt EX-99.1 4440
5 CONSOLIDATED FINANCIAL STATEMENTS y87978exv99w2.txt EX-99.2 142297
6 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS y87978exv99w3.txt EX-99.3 37566
  Complete submission text file 0000950123-03-007589.txt   196618
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 03760580
SIC: 2835 In Vitro & In Vivo Diagnostic Substances